6 TECH OUTLOOKOctober - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIn terms of technology implementations, the field of pharmaceuticals has always had a fragmented and fluctuating approach, and stakeholders within the industry are well aware of this situation. As pharma is subject to a variety of regulations that are in place to control their processes, it is increasingly essential for them to adapt to change, and utilize technology to bring in communication and analytics that can aid them achieve business goals. One challenge that drug developers face in terms of marketing is stagnation, as annual growth rates have witnessed a constant fall over the last few years. Another is adhering to all regulations as they continue to pour in and affect the way drugs are sold in the market. On this front, technology implementations are being acquired at pharmaceuticals to gain access to streamline communication and analytics, and leverage the wares to conduct scientific research, and create an error-free supply chain as well. The way forward for firms within the industry is to acquire digital technologies that allow for a more patient-centric path in terms of healthcare. As patients are more informed than ever before, pharma must acknowledge their feedback to understand how best to move ahead and gain sales momentum. Presently, pharma is treated to an entirely new system infrastructure that not only has them developing new drugs but also for brand building to bridge the gap between them and the rest of the industry world. With this edition of Pharma Tech Outlook on Pharma Marketing, we hope our readers can find the right solution vendors that can aid them to bring about a positive change while they are revamping to nurture working and productive outcomes that can reign in profits.Let us know your thoughts!Drugs: From Manufacturing Unit to Public MarketCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.October - 18 - 2019, Vol 05 - Issue 15 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasJoshua ParkerJustin SmithPaul BarberSalesBrian Thomas brian.thomas@pharmatechoutlook.comsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510-556-2280Fax:510-894-8405Scott JuasyTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >